This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Mikiko Mori: Innovator in Pharmaceutical Composition
Introduction
Mikiko Mori is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of prostate cancer. Her innovative work has led to the development of a unique pharmaceutical composition that addresses endothelin-induced diseases.
Latest Patents
Mikiko Mori holds 1 patent for her invention titled "Remedies for endothelin-induced diseases." This patent describes a pharmaceutical composition that therapeutically treats prostate cancer. The effective component of this composition is N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-2-phenylethenesulfoneamide or a pharmaceutically acceptable salt thereof.
Career Highlights
Mikiko Mori is associated with Yamanouchi Pharmaceutical Company Ltd., where she has been instrumental in advancing research and development in the pharmaceutical sector. Her work has not only contributed to the scientific community but has also provided new hope for patients suffering from prostate cancer.
Collaborations
Mikiko has collaborated with notable colleagues, including Hironori Yuyama and Akira Fujimori. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Mikiko Mori's contributions to pharmaceutical innovation exemplify the impact of dedicated research on healthcare. Her work continues to inspire advancements in the treatment of serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile